REGULATED BIOANALYSIS OF BIOPHARMACEUTICALS – MASS SPECTROMETRY AS ANALYTICAL PLATFORM
11-05-2017 08:30 - 10:30
Arne Jacobsens Allé 15 – Ground floor
DK-2300 - Copenhagen S
Medicon Valley Alliance
Join us at the upcoming Good Morning Meeting and learn about Regulated bioanalysis of biopharmaceuticals – mass spectrometry as analytical platform.
Bioanalysis of peptides, proteins and oligonucleotides by LCMS is a developing science and an addition to the still leading ligand binding analytical techniques. LC-MS can generate complementary information to LBA and therewith provide more accurate insights in PK/PD behavior of a specific macromolecule.
A broad array of mass spectrometry technologies and sample preparation methods can be employed to produce more robust and compliant data.
QPS would like to discuss and share experiences on benefits and drawbacks faced when using LC-MS in regulated bioanalysis of large molecules.